Menlo Park, CA, United States of America

Mikhail L Gishizky

USPTO Granted Patents = 9 


Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 115(Granted Patents)


Location History:

  • Palo Alto, CA (US) (2000 - 2006)
  • Menlo Park, CA (US) (2005 - 2011)

Company Filing History:


Years Active: 2000-2011

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Mikhail L Gishizky: Innovator in Biomarkers and Therapeutics

Introduction

Mikhail L Gishizky is a prominent inventor based in Menlo Park, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of biomarkers and therapeutic applications. With a total of 9 patents to his name, Gishizky's work has the potential to impact the diagnosis and treatment of various diseases.

Latest Patents

Among his latest patents is the invention titled "GEF-H1b: biomarkers, complexes, assays and therapeutic uses thereof." This invention focuses on diagnosing abnormal cell proliferation in biological samples. It also involves screening for drugs that can inhibit, reduce, or abolish cell growth, especially tumorigenic cell growth. The detection of a phosphovariant isoform of a guanine nucleotide exchange factor biomarker, such as the novel GEF-H1S, is a key aspect of this innovation.

Career Highlights

Throughout his career, Gishizky has worked with various companies, including Sugen Incorporated. His expertise in the field has led to numerous advancements in biotechnology and therapeutic development.

Collaborations

Gishizky has collaborated with notable professionals in the industry, including Axel Ullrich and Irmingard Sures. These collaborations have further enhanced his research and contributions to the field.

Conclusion

Mikhail L Gishizky is a distinguished inventor whose work in biomarkers and therapeutics continues to shape the landscape of biotechnology. His innovative patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…